These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17030789)

  • 1. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses.
    Navarini AA; Recher M; Lang KS; Georgiev P; Meury S; Bergthaler A; Flatz L; Bille J; Landmann R; Odermatt B; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15535-9. PubMed ID: 17030789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confounding roles for type I interferons during bacterial and viral pathogenesis.
    Carrero JA
    Int Immunol; 2013 Dec; 25(12):663-9. PubMed ID: 24158954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage of primary infection with lymphocytic choriomeningitis virus determines predisposition or resistance of mice to secondary bacterial infections.
    Gumenscheimer M; Balkow S; Simon MM; Jirillo E; Galanos C; Freudenberg MA
    Med Microbiol Immunol; 2007 Jun; 196(2):79-88. PubMed ID: 17136407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.
    Shepardson KM; Larson K; Morton RV; Prigge JR; Schmidt EE; Huber VC; Rynda-Apple A
    mBio; 2016 May; 7(3):. PubMed ID: 27143388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.
    Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A
    Front Immunol; 2018; 9():2589. PubMed ID: 30473701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung.
    Small CL; Shaler CR; McCormick S; Jeyanathan M; Damjanovic D; Brown EG; Arck P; Jordana M; Kaushic C; Ashkar AA; Xing Z
    J Immunol; 2010 Feb; 184(4):2048-56. PubMed ID: 20083661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of early viral and bacterial distribution and disease by natural antibodies.
    Ochsenbein AF; Fehr T; Lutz C; Suter M; Brombacher F; Hengartner H; Zinkernagel RM
    Science; 1999 Dec; 286(5447):2156-9. PubMed ID: 10591647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.
    Xu HC; Grusdat M; Pandyra AA; Polz R; Huang J; Sharma P; Deenen R; Köhrer K; Rahbar R; Diefenbach A; Gibbert K; Löhning M; Höcker L; Waibler Z; Häussinger D; Mak TW; Ohashi PS; Lang KS; Lang PA
    Immunity; 2014 Jun; 40(6):949-60. PubMed ID: 24909887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virus.
    Leist TP; Aguet M; Hässig M; Pevear DC; Pfau CJ; Zinkernagel RM
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2213-8. PubMed ID: 3612089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional role of type I and type II interferons in antiviral defense.
    Müller U; Steinhoff U; Reis LF; Hemmi S; Pavlovic J; Zinkernagel RM; Aguet M
    Science; 1994 Jun; 264(5167):1918-21. PubMed ID: 8009221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.
    Crouse J; Bedenikovic G; Wiesel M; Ibberson M; Xenarios I; Von Laer D; Kalinke U; Vivier E; Jonjic S; Oxenius A
    Immunity; 2014 Jun; 40(6):961-73. PubMed ID: 24909889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Virus Infection in Deregulating the Cytokine Response to Secondary Bacterial Infection.
    Mehta D; Petes C; Gee K; Basta S
    J Interferon Cytokine Res; 2015 Dec; 35(12):925-34. PubMed ID: 26308503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes.
    Ng CT; Mendoza JL; Garcia KC; Oldstone MB
    Cell; 2016 Jan; 164(3):349-52. PubMed ID: 26824652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes.
    Carrero JA; Calderon B; Unanue ER
    J Exp Med; 2006 Apr; 203(4):933-40. PubMed ID: 16549598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice.
    Lee LN; Burke S; Montoya M; Borrow P
    J Immunol; 2009 Jun; 182(11):7178-89. PubMed ID: 19454715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interferon response to bacterial and viral infections.
    Pietras EM; Saha SK; Cheng G
    J Endotoxin Res; 2006; 12(4):246-50. PubMed ID: 16953977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor.
    Pollak N; Sterns T; Echtenacher B; Männel DN
    Infect Immun; 2005 Oct; 73(10):6488-92. PubMed ID: 16177321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection.
    Robinson KM; Ramanan K; Clay ME; McHugh KJ; Rich HE; Alcorn JF
    Mucosal Immunol; 2018 Jan; 11(1):199-208. PubMed ID: 28401938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection.
    Xu HC; Huang J; Khairnar V; Duhan V; Pandyra AA; Grusdat M; Shinde P; McIlwain DR; Maney SK; Gommerman J; Löhning M; Ohashi PS; Mak TW; Pieper K; Sic H; Speletas M; Eibel H; Ware CF; Tumanov AV; Kruglov AA; Nedospasov SA; Häussinger D; Recher M; Lang KS; Lang PA
    J Virol; 2015 May; 89(9):4748-59. PubMed ID: 25673724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.